Ceramide Analysis in Combination With Genetic Testing May Provide a Precise Diagnosis for Self-Healing Collodion...

Area of Science:

• Genetics
• Dermatology
• Biochemistry

Background:

• Self-healing collodion baby (SHCB) is a rare, mild variant of autosomal recessive congenital ichthyosis.
• Distinguishing SHCB from other congenital ichthyosis forms in neonates is challenging.
• CYP4F22 mutations are implicated in impaired skin barrier function.

Purpose of the Study:

• To investigate the genetic basis and biochemical mechanisms of SHCB.
• To identify diagnostic markers for early and precise diagnosis of SHCB.
• To analyze the role of CYP4F22 in ceramide production and skin barrier integrity.

Main Methods:

• Case study of two Japanese SHCB patients with compound heterozygous mutations in CYP4F22.
• Immunohistochemical analysis of skin biopsies for inflammatory markers (IL-17C, IL-36γ, TNF-α).
• Ceramide analysis in stratum corneum samples via tape stripping and enzyme activity assays for CYP4F22 mutants.

Main Results:

• Identified compound heterozygous mutations in CYP4F22: c.235G>T/c.1189C>T and c.1295A>G/c.1138delG.
• Observed inflammation with elevated IL-17C, IL-36γ, and TNF-α in neonatal SHCB skin.
• Found significantly lower levels of ω-hydroxy fatty acid-containing ceramides (including acylceramides) and protein-bound ceramides in SHCB patients.
• Demonstrated loss of enzyme activity for two identified CYP4F22 mutants (p.(Glu79∗) and p.(Arg397Cys)).

Conclusions:

• CYP4F22 mutations disrupt acylceramide production, impairing the epidermal permeability barrier.
• Genetic testing and noninvasive ceramide analysis show promise for early SHCB diagnosis.
• Understanding CYP4F22's role aids in diagnosing and managing congenital ichthyoses.